Marianna Mancini, Chief Operating Officer at Viking Therapeutics, Inc. (VKTX), sold 237,805 shares at $16.00 ($3.6M) on 2023-03-29, disclosed to the SEC on 2023-03-30.
Open-market sale of $3.6M VKTX by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 196,563 | $2.9M | 81.7% |
| 2 | $16.00 | 41,242 | $660K | 18.3% |
| Total | $15.17 avg | 237,805 | $3.6M | 100% |
| Filing → |
| VKTX | SELL | 2025-10-28 | $216K | — | Filing → |
| VKTX | SELL | 2025-07-03 | $237K | — | Filing → |
| VKTX | SELL | 2025-01-06 | $4.4M | — | Filing → |